News Image

Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity

Provided By GlobeNewswire

Last update: Oct 8, 2025

MENLO PARK, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate long-read sequencing solutions, today announced that the National Institute on Aging’s Long Life Family Study (LLFS) selected PacBio technology to generate comprehensive genomic and epigenomic data from as many as 7,800 participants. The effort will employ PacBio’s Revio systems to capture highly accurate HiFi long-read sequencing data designed to shed light on why longevity runs in families and what drives healthier aging.

Read more at globenewswire.com

PACIFIC BIOSCIENCES OF CALIF

NASDAQ:PACB (10/10/2025, 8:50:25 PM)

After market: 1.41 -0.01 (-0.7%)

1.42

-0.11 (-7.19%)



Find more stocks in the Stock Screener

Follow ChartMill for more